Liu Qiliang, Lei Mei
Department of Pathology of Wuhan Pulmonary Hospital, Wuhan Tuberculosis Prevention and Control Institute, Wuhan, Hubei, 430030, People's Republic of China.
Int J Gen Med. 2025 Jun 17;18:3207-3214. doi: 10.2147/IJGM.S525789. eCollection 2025.
Pulmonary Cryptococcosis (PC) is an invasive pulmonary fungal disease caused by cryptococcal infection, with diagnosis being challenging and prone to misdiagnosis. This research comprehensively analyzes the clinical, imaging, and pathological characteristics of PC, aiming to enhance diagnostic and therapeutic proficiency for PC.
Clinical data of 60 PC patients diagnosed in our hospital from January 2019 to June 2024 were retrospectively scrutinized.
60 patients were enrolled (40 males, 20 females), with an average age of 49.1±13.3 years. Notably, 47 patients (78.3%) were 40 years old or older. 47 cases had chronic underlying diseases, including 2 AIDS patients. Respiratory symptoms were observed in 33 patients, with cough being the most common. Serum cryptococcal capsular antigen testing was conducted on 52 patients, revealing a diagnostic sensitivity of 44.2% (23/52). Imaging revealed predominant involvement of the right lower lung. A peripheral subpleural distribution pattern was observed in 28 cases (46.7%). Lesions exhibited diverse morphologies: solitary, multiple nodules/masses, patchy/consolidation shadows, and a mixed form of these. The mixed type was most prevalent, with 30 cases. Initially, 56 cases were misdiagnosed as tuberculosis, lung cancer or others prior to pathological confirmation. Histopathology showed granulomas and/or multinucleated giant cells in 57 cases. Cryptococcal yeast cells phagocytosed within these cells appeared as colorless, transparent, round or oval structures (4-15 um in diameter) with a refractile clear halo on HE staining, while methenamine silver and PAS staining highlighted them as black or bright-red, facilitating diagnosis. Eleven patients underwent surgical resection followed by fluconazole therapy, and 45 received fluconazole or itraconazole therapy, with most achieving stable outcomes.
PC predominantly impacts men over 40 with chronic comorbidities. Serological tests and imaging may indicate PC, yet a definitive diagnosis necessitates lung biopsy or surgical pathology. Antifungal drugs and/or surgery typically resulted in a favorable prognosis.
肺隐球菌病(PC)是由隐球菌感染引起的侵袭性肺部真菌病,诊断具有挑战性且容易误诊。本研究全面分析了PC的临床、影像学和病理特征,旨在提高PC的诊断和治疗水平。
回顾性分析2019年1月至2024年6月在我院确诊的60例PC患者的临床资料。
纳入60例患者(男性40例,女性20例),平均年龄49.1±13.3岁。值得注意的是,47例患者(78.3%)年龄在40岁及以上。47例有慢性基础疾病,其中包括2例艾滋病患者。33例患者出现呼吸道症状,以咳嗽最为常见。对52例患者进行了血清隐球菌荚膜抗原检测,诊断敏感性为44.2%(23/52)。影像学显示右下肺受累为主。28例(46.7%)观察到外周胸膜下分布模式。病变表现出多种形态:孤立性、多发性结节/肿块、斑片状/实变影以及这些形态的混合形式。混合类型最为常见,有30例。最初,56例在病理确诊前被误诊为肺结核、肺癌或其他疾病。组织病理学显示57例有肉芽肿和/或多核巨细胞。在这些细胞内吞噬的隐球菌酵母细胞在HE染色下呈现为无色、透明、圆形或椭圆形结构(直径4-15μm),周围有折光性清晰光晕,而六胺银和PAS染色将它们染成黑色或鲜红色,便于诊断。11例患者接受手术切除后加用氟康唑治疗,45例接受氟康唑或伊曲康唑治疗,大多数患者病情稳定。
PC主要影响40岁以上有慢性合并症的男性。血清学检查和影像学检查可能提示PC,但明确诊断需要肺活检或手术病理检查。抗真菌药物和/或手术通常预后良好。